Ignite Creation Date:
2025-12-24 @ 9:36 PM
Ignite Modification Date:
2026-01-04 @ 7:00 PM
Study NCT ID:
NCT00576732
Status:
COMPLETED
Last Update Posted:
2014-05-09
First Post:
2007-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-12
Start Date Type:
None
Primary Completion Date:
2009-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-12-17
First Submit QC Date:
None
Study First Post Date:
2007-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-09-02
Results First Submit QC Date:
None
Results First Post Date:
2010-09-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-04-24
Last Update Post Date:
2014-05-09
Last Update Post Date Type:
ESTIMATED